Primary pulmonary myxoid sarcoma with EWSR1::CREB1 fusion: a literature review
Journal of Cancer Research and Clinical Oncology · 29.02.2024 · 150 (3)
DOI: 10.1007/s00432-024-05634-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cancer Research and Clinical Oncology, online erschienen am 29.02.2024. Verfasst von Xinyu Miao und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China. Hauptthemen laut MEDLINE: Chromosome Aberrations, Sarcoma. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Xisike Clinical Oncology Research Foundation.
Abstract (Originalsprache)
Purpose
This review primarily aims to review the epidemiology, clinical characteristics, imaging, pathology, immunohistochemistry, diagnosis, differential diagnosis, treatment, and prognosis of Primary pulmonary myxoid sarcoma (PPMS) with EWS RNA binding protein 1::cAMP response element binding protein 1 (EWSR1::CREB1) fusion. It provides reference for the diagnosis and treatment of this disease.
Methods
Retrospectively collected the literature about PPMS with EWSR1::CREB1 fusion, its clinical, radiology, histology, molecular characteristics and current treatment strategies were collated and analyzed. This review provides a detailed differential diagnosis of the disease.
Results
PPMS is an exceptionally rare, low-grade malignant tumor of the lung. This tumor commonly infiltrates lung tissue and develops within bronchial passages. It is identified by a genetic rearrangement involving the EWSR1 gene and a distinct chromosomal translocation t(2; 22)(q33; q12). Variants include EWSR1::CREB1 fusion and EWS RNA binding protein 1::activating transcription factors (EWSR1::ATF1) fusion. PPMS with EWSR1::CREB1 fusion is more prevalent among middle-aged individuals and affects both sexes almost equally. Clinical symptoms are relatively non-specific, primarily including cough, hemoptysis, and weight loss. Most patients undergo surgery and experience a favorable prognosis. Further research is required to validate the effectiveness of alternative treatments for PPMS with EWSR1::CREB1 fusion.
Conclusion
EWSR1 rearrangement and EWSR1::CREB1 fusion are crucial genetic features of PPMS and serve as important diagnostic markers. Immunohistochemically, PPMS tests positive for EMA. In terms of treatment, surgery has been the primary approach in recent years. Therefore, the efficacy of other treatments still requires further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China.
- Zhejiang Key Laboratory of Diagnosis and Treatment Technology On Thoracic Oncology (Lung and Esophagus), Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, Peo…
- Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, People's Republic of China.
- Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, 310022, People's Republic of China.
- Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, People's Republic of China. luhy@zjcc.org.cn.
Förderung
- Beijing Xisike Clinical Oncology Research Foundation
Zitieren
APA
Miao, X., Chen, J., Yang, L., & Lu, H. (2024). Primary pulmonary myxoid sarcoma with EWSR1::CREB1 fusion: a literature review. Journal of Cancer Research and Clinical Oncology, 150(3). https://doi.org/10.1007/s00432-024-05634-4
Vancouver
Miao X, Chen J, Yang L, Lu H. Primary pulmonary myxoid sarcoma with EWSR1::CREB1 fusion: a literature review. Journal of Cancer Research and Clinical Oncology. 2024;150(3). doi:10.1007/s00432-024-05634-4
BibTeX
@article{Miao2024,
author = {Miao, Xinyu and Chen, Jing and Yang, Lan and Lu, Hongyang},
title = {Primary pulmonary myxoid sarcoma with EWSR1::CREB1 fusion: a literature review},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
volume = {150},
number = {3},
doi = {10.1007/s00432-024-05634-4}
}
EUVIMED